Search research articles
Contact Us
Filters
Showing results (21-30 of 58) with videos related to
Page
of 6
Sort By:
The American Journal of Physiology
|
October 8, 1997
1,25 (OH)2D3 enhances PTH-induced Ca2+ transients in preosteoblasts by activating L-type Ca2+ channels
W Li, R L Duncan, N J Karin, et al.
Journal of Dental Research
|
January 11, 2017
Artificial Induction of Native Aquaporin-1 Expression in Human Salivary Cells
Z Wang, S Pradhan-Bhatt, M C Farach-Carson, et al.
Endocrinology
|
December 1, 1994
Target gene activation by 1,25-dihydroxyvitamin D3 in osteosarcoma cells is independent of calcium influx
R Khoury, A L Ridall, A W Norman, et al.
The Journal of Biological Chemistry
|
December 20, 1996
Down-regulation of L-type Ca2+ channel transcript levels by 1,25-dihyroxyvitamin D3. Osteoblastic cells express L-type alpha1C Ca2+ channel isoforms
J G Meszaros, N J Karin, K Akanbi, et al.
Journal of Musculoskeletal & Neuronal Interactions
|
March 11, 2005
Perlecan: an important component of the cartilage pericellular matrix
R Gomes, C Kirn-Safran, M C Farach-Carson, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
June 1, 1994
Immunolocalization of osteopontin, osteocalcin, and dentin sialoprotein during dental root formation and early cementogenesis in the rat
A L Bronckers, M C Farach-Carson, E Van Waveren, et al.
Cell Calcium
|
March 22, 2000
Calcium signals in prostate cancer cells: specific activation by bone-matrix proteins
V Lecrone, W Li, R E Devoll, et al.
Biochemical and Biophysical Research Communications
|
June 30, 2000
1,25 dihydroxyvitamin D(3) activates sphingomyelin turnover in ROS17/2.8 osteosarcoma cells without sphingolipid-induced changes in cytosolic Ca(2+)
R Liu, Y Xu, M C Farach-Carson, et al.
Tissue Engineering
|
March 2, 2005
Perlecan domain I promotes fibroblast growth factor 2 delivery in collagen I fibril scaffolds
W D Yang, R R Gomes, M Alicknavitch, et al.
Current Opinion in Chemical Engineering
|
March 18, 2014
TISSUE ENGINEERING PERFUSABLE CANCER MODELS
E L Fong, M Santoro, M C Farach-Carson, et al.
Page
of 6
Search research articles
Search
Showing results (21-30 of 58) with videos related to
Sort By:
Page
of 6
The American Journal of Physiology
|
October 8, 1997
1,25 (OH)2D3 enhances PTH-induced Ca2+ transients in preosteoblasts by activating L-type Ca2+ channels
W Li, R L Duncan, N J Karin, et al.
Journal of Dental Research
|
January 11, 2017
Artificial Induction of Native Aquaporin-1 Expression in Human Salivary Cells
Z Wang, S Pradhan-Bhatt, M C Farach-Carson, et al.
Endocrinology
|
December 1, 1994
Target gene activation by 1,25-dihydroxyvitamin D3 in osteosarcoma cells is independent of calcium influx
R Khoury, A L Ridall, A W Norman, et al.
The Journal of Biological Chemistry
|
December 20, 1996
Down-regulation of L-type Ca2+ channel transcript levels by 1,25-dihyroxyvitamin D3. Osteoblastic cells express L-type alpha1C Ca2+ channel isoforms
J G Meszaros, N J Karin, K Akanbi, et al.
Journal of Musculoskeletal & Neuronal Interactions
|
March 11, 2005
Perlecan: an important component of the cartilage pericellular matrix
R Gomes, C Kirn-Safran, M C Farach-Carson, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
June 1, 1994
Immunolocalization of osteopontin, osteocalcin, and dentin sialoprotein during dental root formation and early cementogenesis in the rat
A L Bronckers, M C Farach-Carson, E Van Waveren, et al.
Cell Calcium
|
March 22, 2000
Calcium signals in prostate cancer cells: specific activation by bone-matrix proteins
V Lecrone, W Li, R E Devoll, et al.
Biochemical and Biophysical Research Communications
|
June 30, 2000
1,25 dihydroxyvitamin D(3) activates sphingomyelin turnover in ROS17/2.8 osteosarcoma cells without sphingolipid-induced changes in cytosolic Ca(2+)
R Liu, Y Xu, M C Farach-Carson, et al.
Tissue Engineering
|
March 2, 2005
Perlecan domain I promotes fibroblast growth factor 2 delivery in collagen I fibril scaffolds
W D Yang, R R Gomes, M Alicknavitch, et al.
Current Opinion in Chemical Engineering
|
March 18, 2014
TISSUE ENGINEERING PERFUSABLE CANCER MODELS
E L Fong, M Santoro, M C Farach-Carson, et al.
Page
of 6